Monsoon Communications

News Monsoon Communications

• Abraxane plus gemcitabine improves survival in phase III study of patients with advanced pancreatic cancer

  Specialised Therapeutics Australia announced that a phase III clinical trial of breast cancer drug ABRAXANE® (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival t more

• Biotron completes clinical stage of HIV clinical trial

  Biotron Limited (BIT) has completed the clinical stage of a landmark phase 1b/2a proof-of-concept human trial of its lead HIV drug candidate, BIT225. The placebo-controlled, double-blinded study was undertaken at a clinical trial unit in Bangkok, Thailand. Patients enrolled in the trial were HIV-pos more

• CAVATAK Phase II Melanoma Study achieves interim efficacy subgoal

  Viralytics Limited (VLA) in its US-based Phase II melanoma trial of its virotherapy candidate CAVATAKTM has achieved an interim efficacy subgoal of three Objective Responses (OR). This follows a recent review by the independent Data Monitoring Committee (DMC) of the trial. In the Phase II trial prot more

Websites Monsoon Communications